ACTRN12609000677202已完成2 期
Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 50 Years 至 74 Years（—）
- 性别
- All
入选标准
- •Patients aged 50-74 years, taking one or more medicines for cholesterol or hypertension, and without established cardiovascular disease or a cardiovascular event
排除标准
- •1. patients with a complex debilitating coexisting medical condition (e.g. mental illness, end-stage cancer)
- •2. Previously-identified diabetes
- •3. Target organ damage
- •4. Any cognitive impairment
- •5. Dependent patients relying on a carer or living in a residential aged care facility
- •6. Recent hospital inpatients who were medical admissions and discharged less than four weeks prior to recruitment
- •7. Non-English speaking
- •8. Living more than 40 km from a participating pharmacy
- •9. Patients who have received a Home Medication Review (HMR) in the past 12 months
- •10. Patients whose GP has deemed them inappropriate for this intervention
- •Patients of GPs who express a desire not to have any involvement with this project
研究者
相似试验
尚未招募
Unknown
to study the medication adherence of anti-HIV medicines in people living with HIV/AIDSCTRI/2023/03/051142GGS Medical college and Hospital
尚未招募
不适用
Medication adherence and management of risk factors for secondary stroke preventioCTRI/2022/06/042980World Stroke Organization
已完成
不适用
Impact of pharmacist interventions on adherence and patient outcomes among depressed patients.DepressionISRCTN34879893Al Amal Psychiatric Hospital195
尚未招募
不适用
A study on pattern of medicines prescribed, adherence of medications to treatment guidelines and awareness of lifestyle modification in patients of polycystic ovary syndrome.CTRI/2019/07/020180Diamond Jubilee Society Trust KEM Hospital
已完成
不适用
Examination of medication adherence and physical / mental function improvement effect of combination tablets (SGLT2-I and DPP4-I)Type 2 diabetes mellitusJPRN-UMIN000045375Kurume University School of Medicine Division of Endocrinology and Metabolism, Department of Internal Medicine39